Effect of hydrochloride fasudil on serum TGF-β1 and MCP-1 in early diabetic nephrosis patients was written by Huang, Cong. And the article was included in Biaoji Mianyi Fenxi Yu Linchuang in 2015.Recommanded Product: 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride This article mentions the following:
Objective To explore the changes of serum TGF-β1 and MCP-1 in diabetic nephrosis patients after treated with Fasudil injection. Methods 100 early diabetic nephrosis patients were randomly divided into the group A (control group,50 cases) and group B(50 cases). AU patients received routine therapy, while patients in group B were addnl. given fasudil injection for 2 wk. The level of serum TGF-β1 and MCP-1 were measured by the ELISA before and after the treatment. Results After the treatment, the levels of TGF-β1 and MCP-1 in group A had not significant Changes(P>0.05), While the levels of TGF-β1 and MCP-1 in group B after treatment were much lower than that of before treatment(P <0.05). The decrease of TGF-β1 and MCP-1 were more significant in group B than that of in group A after treatment( P < 0.05). Conclusion On the basis of routine therapy, Fasudil injection could inhibit the expression of TGF-β1 and MCP-1, which has good curative effect on early diabetic nephrosis. In the experiment, the researchers used many compounds, for example, 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7Recommanded Product: 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride).
5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7) belongs to isoquinoline derivatives. Quinoline and isoquinoline skeletons are among the most attractive frameworks with a wide range of biological and pharmacological activities. Isoquinoline-type alkaloids show biological activities similar to those of morphinane-, protoberberine-, and benzophenanthridine-type alkaloids.Recommanded Product: 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride
Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem